Biogen Income Statement

Health Care & Life Sciences » Biotechnology | Biogen Inc.

Biogen Inc. | Income Statement

Fiscal year is January-December. All values USD Millions.

2013

2014

2015

2016

2017

2018

Sales/Revenue

5,860

8,582

9,321

10,194

10,990

12,053

Cost of Goods Sold (COGS) incl. D&A

1,201

1,610

1,623

1,807

2,414

2,198

Gross Income

4,660

6,973

7,698

8,387

8,577

9,855

SG&A Expense

3,241

4,126

3,921

4,171

4,693

EBIT

1,418

2,847

3,572

4,466

4,406

5,163

Unusual Expense

143

587

225

476

Non Operating Income/Expense

142

Interest Expense

260

246

201

Pretax Income

2,481

3,947

4,767

4,933

5,129

5,900

Income Tax

601

990

1,162

1,237

2,459

1,426

Equity in Affiliates

Consolidated Net Income

1,862

2,942

3,593

3,696

2,670

4,474

Net Income

1,862

2,935

3,547

3,703

2,539

4,431

Net Income After Extraordinaries

1,862

2,935

3,547

3,703

2,539

4,431

Net Income Available to Common

1,862

2,935

3,547

3,703

2,539

4,431

EPS (Basic)

7.81

12.37

15.34

16.92

11.92

21.58

Basic Shares Outstanding

237

236

231

218

213

205

EPS (Diluted)

7.81

12.37

15.34

16.92

11.92

21.58

Diluted Shares Outstanding

238

237

231

219

213

205

EBITDA

1,950

3,484

4,172

5,149

5,456

5,813

Non-Operating Interest Income

113

Minority Interest Expense

131

Equity in Affiliates (Pretax)

1,085

1,114

1,270

1,239

1,204

1,247

About Biogen

View Profile

Address	225 Binney Street Cambridge Massachusetts 02142 United States
Employees	-
Website	http://www.biogen.com
Updated	07/08/2019
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Biogen Inc. | Income Statement

About Biogen

StatInvestor